Literature DB >> 11487304

Effects of conjugated linoleic acids and docosahexaenoic acid on rat liver and reproductive tissue fatty acids, prostaglandins and matrix metalloproteinase production.

M A Harris1, R A Hansen, P Vidsudhiphan, J L Koslo, J B Thomas, B A Watkins, K G Allen.   

Abstract

Long chain n-6 and n-3 fatty acids play important roles in labor and delivery. These effects may be mediated by prostaglandin (PG) synthesis and by regulation of matrix metalloproteinases (MMPs), both of which play roles in uterine contraction, cervical ripening and rupture of fetal membranes. The effects of altering dietary n-6:n-3 long chain fatty acid ratios, and the addition of dietary conjugated linoleic acids (CLA) and docosahexaenoic acid (DHA) on fatty acid composition of reproductive tissues, PG synthesis in liver and reproductive tissue and serum MMP levels were examined in pregnant rats. Modified AIN-96G diets with n-6:n-3 ratios of 7:1 and 34:1 with and without added 1.1% (by weight) conjugated linoleic acid (CLA) and/or 0.3% (by weight) DHA were fed through day 20 of gestation. Reproductive tissues readily incorporated both DHA and CLA. CLA significantly (P<0.05) depressed PGF(2 alpha)synthesis in placenta, uterus and liver by 50% when the n-6:n-3 ratio was 7:1 and by 66% at 34:1 ratio. Significant differences (P<0.05) in PGE(2)synthesis in uterus and liver were seen only between groups fed the high ratio of n-6:n-3 without CLA, and the low ratio with CLA. Addition of CLA to DHA containing diets depressed PGF(2alpha) by one-third in uterus and liver (P<0.05). Serum MMP-9 and active MMP-2 were suppressed (P<0.05) by addition of either CLA or DHA. Copyright 2001 Harcourt Publishers Ltd.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11487304     DOI: 10.1054/plef.2001.0283

Source DB:  PubMed          Journal:  Prostaglandins Leukot Essent Fatty Acids        ISSN: 0952-3278            Impact factor:   4.006


  15 in total

1.  Omega-6 fatty acids down-regulate matrix metalloproteinase expression in a coronary heart disease-induced rat model.

Authors:  Nihong Lu; Yingrong Du; Haiyuan Li; Yu Luo; Bing Ouyang; Yangjun Chen; Yongrui Yang; Lixia Yang
Journal:  Int J Exp Pathol       Date:  2018-11-15       Impact factor: 1.925

Review 2.  Omega-3 fatty acids and the regulation of expression of endothelial pro-atherogenic and pro-inflammatory genes.

Authors:  R De Caterina; M Massaro
Journal:  J Membr Biol       Date:  2005-07       Impact factor: 1.843

3.  Omega-3 fatty acid supplementation decreases matrix metalloproteinase-9 production in relapsing-remitting multiple sclerosis.

Authors:  L Shinto; G Marracci; S Baldauf-Wagner; A Strehlow; V Yadav; L Stuber; D Bourdette
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2009-01-25       Impact factor: 4.006

4.  The Level of Testosterone, Vitamin D, and Irregular Menstruation More Important than Omega-3 in Non-Symptomatic Women Will Define the Fate of Multiple Scleroses in Future.

Authors:  Shima Tavakol; Sahar Shakibapour; Sepideh Arbabi Bidgoli
Journal:  Mol Neurobiol       Date:  2016-12-13       Impact factor: 5.590

Review 5.  Matrix metalloproteinase inhibitors (MMPIs) from marine natural products: the current situation and future prospects.

Authors:  Chen Zhang; Se-Kwon Kim
Journal:  Mar Drugs       Date:  2009-03-31       Impact factor: 5.118

6.  Dietary conjugated linoleic acid renal benefits and possible toxicity vary with isomer, dose and gender in rat polycystic kidney disease.

Authors:  Malcolm R Ogborn; Evan Nitschmann; Aviva Goldberg; Neda Bankovic-Calic; Hope A Weiler; Harold M Aukema
Journal:  Lipids       Date:  2008-07-16       Impact factor: 1.880

7.  Inhibitory effect of polyunsaturated fatty acids on MMP-9 release from microglial cells--implications for complementary multiple sclerosis treatment.

Authors:  Grazia Maria Liuzzi; Tiziana Latronico; Rocco Rossano; Sandra Viggiani; Anna Fasano; Paolo Riccio
Journal:  Neurochem Res       Date:  2007-07-11       Impact factor: 3.996

Review 8.  Polyunsaturated fatty acids and their potential therapeutic role in multiple sclerosis.

Authors:  Lahar R Mehta; Robert H Dworkin; Steven R Schwid
Journal:  Nat Clin Pract Neurol       Date:  2009-02

9.  Metalloproteinase inhibitors: status and scope from marine organisms.

Authors:  Noel Vinay Thomas; Se-Kwon Kim
Journal:  Biochem Res Int       Date:  2010-12-09

10.  A novel oral nutraceutical formula of omega-3 and omega-6 fatty acids with vitamins (PLP10) in relapsing remitting multiple sclerosis: a randomised, double-blind, placebo-controlled proof-of-concept clinical trial.

Authors:  Marios C Pantzaris; George N Loukaides; Evangelia E Ntzani; Ioannis S Patrikios
Journal:  BMJ Open       Date:  2013-04-17       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.